Skip to main content
Erschienen in: Head and Neck Pathology 1/2024

01.12.2024 | Research

The Depth of Invasion and Level IV Cervical Node Metastasis in Patients with Clinically N0 Tongue Cancer

verfasst von: Imdat Yüce, Aslıhan Oflaz Çapar, Veli Çetinaslan, Kemal Deniz, Alperen Vural, Sedat Çağlı, Serap Doğan, Mete Gündoğ

Erschienen in: Head and Neck Pathology | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

The accurate indication for level IV dissection is crucial for preventing complications such as phrenic nerve damage and chylous fistulas in clinically N0 tongue cancer. Although the depth of invasion is an established independent risk factor for occult lymph node metastasis in tongue cancer, its relationship with level IV metastasis has not been evaluated. This study investigated the relationship between the depth of invasion and level IV nodal metastasis in clinically N0 tongue cancer.

Methods

We retrospectively investigated clinical N0 patients who underwent glossectomy and level I–IV neck dissection. We examined lymph node metastasis, risk factors, and the relationship between depth of invasion and metastasis.

Results

Our study included 58 patients, and no patient had isolated level IV metastasis. Additionally, there was no level IV metastasis in well-differentiated tumors. Tumor size, depth of invasion, differentiation, and perineural invasion were significantly associated with level IV neck metastasis. We found a critical tumor size of 2.5 cm and depth of invasion of 8 mm for level IV neck metastasis.

Conclusion

Based on our findings, we recommend that level IV dissection should be considered for poorly differentiated tumors, tumors greater than 2.5 cm in size, and those deeper than 8 mm. This study highlights the importance of depth of invasion as a prognostic factor for predicting level IV metastasis and suggests that our findings can be used to prevent unnecessary level IV dissections that may lead to complications in tongue cancer surgery.
Literatur
3.
Zurück zum Zitat Rusthoven K, Ballonoff A, Raben D, Chen C (2008) Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma. Cancer 112(2):345–351CrossRefPubMed Rusthoven K, Ballonoff A, Raben D, Chen C (2008) Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma. Cancer 112(2):345–351CrossRefPubMed
4.
Zurück zum Zitat Farquhar DR, Tanner AM, Masood MM et al (2018) Oral tongue carcinoma among young patients: an analysis of risk factors and survival. Oral Oncol. 84:7–11CrossRefPubMed Farquhar DR, Tanner AM, Masood MM et al (2018) Oral tongue carcinoma among young patients: an analysis of risk factors and survival. Oral Oncol. 84:7–11CrossRefPubMed
5.
Zurück zum Zitat Lydiatt WM, Patel SG, Sullivan B et al (2017) Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual. Cancer J Clin 67(2):122–137CrossRef Lydiatt WM, Patel SG, Sullivan B et al (2017) Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual. Cancer J Clin 67(2):122–137CrossRef
11.
18.
Zurück zum Zitat Crean SJ, Hoffman A, Potts J, Fardy M (2003) Reduction of occult metastatic disease by extension of the supraomohyoid neck dissection to include level IV. Head & Neck 25(9):758–762CrossRef Crean SJ, Hoffman A, Potts J, Fardy M (2003) Reduction of occult metastatic disease by extension of the supraomohyoid neck dissection to include level IV. Head & Neck 25(9):758–762CrossRef
19.
Zurück zum Zitat Shah J, Andersen P (1995) Evolving role of modifications in neck dissection for oral squamous carcinoma. Br J Oral Maxillofac Surg. 33(1):3–8CrossRefPubMed Shah J, Andersen P (1995) Evolving role of modifications in neck dissection for oral squamous carcinoma. Br J Oral Maxillofac Surg. 33(1):3–8CrossRefPubMed
20.
Zurück zum Zitat Ferlito A, Mannarà GM, Rinaldo A, Politi M, Robiony M, Costa F (2000) Is extended selective supraomohyoid neck dissection indicated for treatment of oral cancer with clinically negative neck? Acta Otolaryngol. 120(7):792–795CrossRefPubMed Ferlito A, Mannarà GM, Rinaldo A, Politi M, Robiony M, Costa F (2000) Is extended selective supraomohyoid neck dissection indicated for treatment of oral cancer with clinically negative neck? Acta Otolaryngol. 120(7):792–795CrossRefPubMed
23.
Zurück zum Zitat Sarkaria JN, Harari PM (1994) Oral tongue cancer in young adults less than 40 years of age: rationale for aggressive therapy. Head Neck 16(2):107–111CrossRefPubMed Sarkaria JN, Harari PM (1994) Oral tongue cancer in young adults less than 40 years of age: rationale for aggressive therapy. Head Neck 16(2):107–111CrossRefPubMed
24.
Zurück zum Zitat Harris SL, Kimple RJ, Hayes DN, Couch ME, Rosenman JG (2010) Never-smokers, never-drinkers: unique clinical subgroup of young patients with head and neck squamous cell cancers. Head Neck: J Sci Special Head Neck 32(4):499–503CrossRef Harris SL, Kimple RJ, Hayes DN, Couch ME, Rosenman JG (2010) Never-smokers, never-drinkers: unique clinical subgroup of young patients with head and neck squamous cell cancers. Head Neck: J Sci Special Head Neck 32(4):499–503CrossRef
26.
Zurück zum Zitat Goldstein DP, Irish JC (2005) Head and neck squamous cell carcinoma in the young patient. Curr Opin Otolaryngol Head Neck Surg 13(4):207–211CrossRefPubMed Goldstein DP, Irish JC (2005) Head and neck squamous cell carcinoma in the young patient. Curr Opin Otolaryngol Head Neck Surg 13(4):207–211CrossRefPubMed
27.
34.
Zurück zum Zitat Sparano A, Weinstein G, Chalian A, Yodul M, Weber R (2004) Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol—Head Neck Surg 131(4):472–476CrossRefPubMed Sparano A, Weinstein G, Chalian A, Yodul M, Weber R (2004) Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol—Head Neck Surg 131(4):472–476CrossRefPubMed
41.
Zurück zum Zitat Tam S, Amit M, Zafereo M, Bell D, Weber RS (2019) Depth of invasion as a predictor of nodal disease and survival in patients with oral tongue squamous cell carcinoma. Head Neck 41(1):177–184CrossRefPubMed Tam S, Amit M, Zafereo M, Bell D, Weber RS (2019) Depth of invasion as a predictor of nodal disease and survival in patients with oral tongue squamous cell carcinoma. Head Neck 41(1):177–184CrossRefPubMed
45.
Zurück zum Zitat Shah JP, Candela FC, Poddar AK (1990) The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer 66(1):109–113CrossRefPubMed Shah JP, Candela FC, Poddar AK (1990) The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer 66(1):109–113CrossRefPubMed
46.
Zurück zum Zitat Li XM, Wei WI, Guo XF, Yuen PW, Lam LK (1996) Cervical lymph node metastatic patterns of squamous carcinomas in the upper aerodigestive tract. J Laryngol Otol 110(10):937–941CrossRefPubMed Li XM, Wei WI, Guo XF, Yuen PW, Lam LK (1996) Cervical lymph node metastatic patterns of squamous carcinomas in the upper aerodigestive tract. J Laryngol Otol 110(10):937–941CrossRefPubMed
Metadaten
Titel
The Depth of Invasion and Level IV Cervical Node Metastasis in Patients with Clinically N0 Tongue Cancer
verfasst von
Imdat Yüce
Aslıhan Oflaz Çapar
Veli Çetinaslan
Kemal Deniz
Alperen Vural
Sedat Çağlı
Serap Doğan
Mete Gündoğ
Publikationsdatum
01.12.2024
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 1/2024
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-024-01647-0

Weitere Artikel der Ausgabe 1/2024

Head and Neck Pathology 1/2024 Zur Ausgabe

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Thiopental Originalie

Als Folge des Urteils des Bundesverfassungsgerichts zur Sterbehilfe im Jahr 2020 wurde in den Jahren 2021–2023 eine Reihe (n = 23) von assistierten Suiziden im Landesinstitut für gerichtliche und soziale Medizin Berlin mit jeweils identischen …

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …